Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies Academic Article Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Lymphoma, Non-Hodgkin

abstract

  • We describe three patients with known or suspected small-cell lung cancer (SCLC), paraneoplastic neurological syndromes, and antineuronal antibodies who had unusually benign clinical courses. One patient survived 8 years free of disease and was positive for the anti-Hu antibody. A second patient survived 6 years after spontaneous tumour regression and had an atypical antineuronal antibody. A third patient with both the anti-Hu and atypical antineuronal antibody had spontaneous regression of a lung mass. All three patients had a subacute sensory neuropathy. Since paraneoplastic antineuronal antibodies also bind to tumour cells, these cases suggest that some (paraneoplastic) neurological syndromes without identifiable tumour may result from immune-mediated eradication of tumour cells.

publication date

  • January 2, 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/0140-6736(93)92485-C

PubMed ID

  • 8093269

Additional Document Info

start page

  • 21

end page

  • 2

volume

  • 341

number

  • 8836